相关实验视频
Updated: Jun 22, 2025
08:56
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
863
间歇性老化疗法对绝经后妇女骨代谢的影响:一项2期随机对照试验
Joshua N Farr1,2, Elizabeth J Atkinson3, Sara J Achenbach3
1Division of Endocrinology, Diabetes and Metabolism, Mayo Clinic, Rochester, MN, USA. farr.joshua@mayo.edu.
Nature medicine
|July 2, 2024
概括
高龄化药物达沙替尼加奎尔丁 (D+Q) 并没有降低绝经后妇女的骨质再吸收. 然而,具有高衰老细胞负担的个体表现出更好的骨标记和密度,这表明衰老细胞负担可能会影响衰老治疗反应.
科学领域:
- 老年学是指老年学的学科.
- 细胞生物学 细胞生物学
- 临床试验 临床试验
背景情况:
- 衰老细胞随着年龄的增长而积累,并导致与年龄相关的疾病,包括骨质损失.
- 衰老药是一种选择性消除衰老细胞的药物.
- 临床前研究表明,老年化药物可以延缓与年龄相关的骨质损失.
研究的目的:
- 评估间歇性达沙替尼加奎尔丁 (D+Q) 在降低绝经后妇女骨质再吸收的疗效.
- 评估D+Q对骨形成标记物和骨矿物质密度的影响.
- 探索衰老细胞负担是否影响骨对D+Q的反应.
主要方法:
- 一个2期随机对照试验,涉及60名绝经后妇女.
- 与对照组相比,间歇性给予D+Q.
- 主要终点:20周后骨再吸收标记CTx的变化.
- 二级终点:骨形成标志物P1NP的变化和骨矿物质密度.
主要成果:
- 20周后D+Q和对照组之间CTx水平没有显著差异.
- 在D + Q组中,P1NP水平在2周和4周显著增加,但在20周没有.
- 探索性分析显示,患有高衰老细胞负担 (高p16mRNA) 的女性在D+Q治疗时,P1NP增加,CTx减少,半径骨矿物密度增加.
结论:
- 间歇性D + Q治疗并没有降低绝经后妇女总体队列的骨质再吸收.
- 探索性发现表明,衰老细胞负担可能是决定对老化药物临床反应的关键因素.
- 需要进一步的研究来调查衰老细胞负担在骨健康的老化疗法中的作用.
更多相关视频
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
490
03:56Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention
Published on: April 26, 2024
586
相关概念视频
01:40Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
01:29Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K